Christina Carone

Prior to joining Weil, Christina was an associate at another international law firm. Christina has experience advising multinational companies on the safety of chemical substances for food-contact applications; drafting legal opinion letters on the compliance status of food additives and food-contact substances in multiple jurisdictions; developing strategies to help food-contact product manufacturers bring their products to market; conducting regulatory diligence reviews; and preparing regulatory filings on behalf of clients regarding U.S. Food and Drug Administration matters.

Christina has been part of the teams advising:

FDA Regulatory Matters

• Advent International, L.P. in its acquisition of Sauer Brands, Inc. from a special purpose vehicle managed by Falfurrias Capital Partners
• Astorg Partners and its portfolio company Hamilton Thorne Ltd in its acquisition of the assisted reproductive technology and cytogenetics business unit of FUJIFILM Irvine Scientific, Inc.
• Astorg Partners in its acquisition of the ART product portfolio of Cook Medical and simultaneous take-private acquisition of Hamilton Thorne Ltd
• Astorg Partners in its approximately CAD $388 million ($283 million) take-private acquisition of Hamilton Thorne Ltd, together with its acquisition of the ART product portfolio of Cook Medical
• Aterian Investment Partners and its portfolio company Vantedge Medical in its acquisition of Hobson & Motzer, Inc.
• Avista Capital Partners and its portfolio company WellSpring Consumer Healthcare in its acquisition of a portfolio of over-the-counter skincare brands from Bayer AG
• Avista Capital Partners and its portfolio company WellSpring Consumer Healthcare in its acquisition of vH essentials from Wisconsin Pharmacal Company
• Avista Capital Partners in its acquisition of WellSpring Consumer Healthcare from Audax Group
• Barilla International BV in its pending acquisition of Gooder Foods, Inc. (d/b/a GOODLES)
• Clayton Dubilier & Rice and its portfolio company Cynosure LLC in its pending sale to Lutronic Corporation
• Eli Lilly and Company in its $10 million acquisition of certain assets from Organovo Holdings, Inc.
• Eli Lilly and Company in its acquisition of a first-in-class small molecule and related assets from a sponsor-backed research consortium
• Eli Lilly and Company in its acquisition of a manufacturing facility in Pleasant Prairie, Wisconsin
• Eli Lilly and Company in the sale of ImClone Systems LLC to Celltrion, Inc.
• Halozyme Therapeutics, Inc. in its $400 million acquisition of Surf Bio, Inc.
• Halozyme Therapeutics, Inc. in its $960 million acquisition of Antares Pharma, Inc.
• Hologic Capital Holdings, Inc. in its pending $350 million acquisition of Gynesonics, Inc.
• Montagu Private Equity and its portfolio company RTI Surgical, Inc. in its acquisition of Cook Biotech Incorporated and Cook Biotech Europe ApS from Cook Group Incorporated
• Montagu Private Equity LLP, through its affiliate Titan Luxco SCA, in its acquisition of Tyber Medical LLC and agreements to acquire majority interests in Opale Topco and Resolve Topco, LP
• PAI Partners in its acquisition of Alphia Inc. from J.H. Whitney Capital Partners
• Sanofi in its approximately $2.2 billion acquisition of Inhibrx, Inc., following the spin-off of its non-INBRX-101 assets
• Sanofi in its approximately $2.9 billion tender offer to acquire Provention Bio Inc.
• Sanofi in its $9.5 billion tender offer to acquire Blueprint Medicines Corporation, including potential contingent value right payments
• Sanofi S.A. in its approximately $2.2 billion tender offer to acquire Dynavax Technologies Corporation
• Stripes, LLC and its portfolio company Siete Foods in its $1.2 billion sale to PepsiCo, Inc.

CFIUS / Export Controls Matters

• Advent International, L.P. and its portfolio companies Ultra PCS Limited and Ultra Electronics, Inc. in the $1.55 billion sale of Ultra PCS Limited, Ultra Electronics ICE, Inc. and Ultra Electronics Precision Air & Land Systems, LLC to Eaton Corporation plc
• Advent International, L.P. in its £3.8 billion ($5.1 billion) take-private acquisition of Spectris plc
• Advent International, L.P., as sponsor, in its $400 million acquisition of the aerospace and defense business of Coherent Corp.
• Aterian Investment Partners and its portfolio company Vantedge Medical in its acquisition of Hobson & Motzer, Inc.
• Brookfield Asset Management and Schoeller Allibert in its merger with Intelligent Packaging Limited, creating a combined business with pro forma annual revenue exceeding $1.4 billion
• Clayton Dubilier & Rice and its portfolio company Cynosure LLC in its pending sale to Lutronic Corporation
• Eli Lilly and Company in the sale of ImClone Systems LLC to Celltrion, Inc.
• Greater Sum Ventures and its portfolio company Utility Associates, Inc. in its acquisition of SOMA Global, Inc.
• H.I.G. Capital in its approximately C$1.3 billion ($907 million) take-private acquisition of Converge Technology Solutions Corp.
• Jack Creek Investment Corp in its business combination with Bridger Aerospace Group Holdings, LLC in a transaction valuing Bridger at $869 million
• Montagu Private Equity LLP, through its affiliate Titan Luxco SCA, in its acquisition of Tyber Medical LLC and agreements to acquire majority interests in Opale Topco and Resolve Topco, LP
• Project Sentinel Purchaser, LLC in its acquisition of Strax Technologies, LLC
• PSG Equity L.L.C. in its acquisition of Glasswall Holdings Limited from IPGL Limited and other shareholders
• PX3 Partners and its portfolio company Cleanova in its $1.3 billion acquisition of Micronics Engineered Filtration Group Inc. from Vance Street Capital
• Seven2 and its portfolio company Vitaprotech Group SAS in its acquisition of the physical security, access card and identity reader operations and assets of Identiv, Inc.

Christina received her LL.M. from Georgetown University Law Center and her J.D., magna cum laude, from Touro Law Center, where she was a student in the Two-Year Accelerated J.D. Program. While in law school, she served as a judicial extern to the Honorable Arthur D. Spatt of the U.S. District Court for the Eastern District of New York and published a note for the Touro Law Review. Christina was also a recipient of CALI Awards for Patent Law, Torts, Legal Process I, Professional Responsibility, Children & the Law, Family Law Practice Module and Civil Dispute Resolution & Procedure. Christina received her B.S., cum laude, from the University of Florida. Prior to law school, Christina acquired extensive knowledge about the healthcare industry while working as a medical assistant and scribe.